Press Releases
TxCell presents final positive results of the phase I/II clinical trial with antigen-specific Treg cells in Crohn’s disease
TxCell SA, a biotechnology company developing Treg cell-based immunotherapies for the treatment of severe chronic inflammatory diseases with high unmet medical needs, announces today...
Press Releases
Taconic and Oncodesign announce agreement to co-promote and co-develop solutions to advance oncology research
Taconic, a leading provider of life sciences solutions, and Oncodesign(R), an innovative leader in the discovery of novel anti-cancer therapies, announce today that they have...
Press Releases
Rib-X Pharmaceuticals’ RX-04 Program Yields Compounds with In Vitro Potency Against Multi-drug Resistant P. aeruginosa
Rib-X Pharmaceuticals, Inc. announced that results from the Company's RX-04 development program will be featured today in the Novel Antimicrobial Agents poster session at...
Press Releases
Further European Regulatory Review Clarifies and Confirms Prior CHMP Position on Positive Benefit-Risk Balance for Pioglitazone-Containing Products
Takeda Pharmaceutical Company Limited announced that at the request of the European Commission (EC), the European Medicines Agency (EMA)’s Committee for Medical Products for Human...
Press Releases
Cook Medical’s Zilver® PTX® Drug-Eluting Stent Technology Receives Unanimous Recommendation from FDA Advisory Committee
The Zilver® PTX® Drug-Eluting Stent, the first device of its kind developed to treat peripheral artery disease (PAD) in the superficial femoral artery (SFA),...
Press Releases
Hybrigenics and Servier enter into a licence and research collaboration agreement in oncology and other therapeutic fields
Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, and Servier, the largest French privately-owned pharmaceutical company, announces today that they have signed...
Press Releases
Global Bio-Pharma Clinical Leaders Call for Industry Transformation at 21st Annual Partnerships in Clinical Trials
Clinical development, outsourcing and operations decision makers from the world’s top bio-pharmaceutical and medical device manufacturers and their clinical research partners will meet on March...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.